サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1587585

骨形成タンパク質の市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント予測、2025年～2030年

Bone Morphogenetic Protein Market Size, Share & Trends Analysis Report By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
骨形成タンパク質の市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年10月14日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

骨形成タンパク質市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の骨形成タンパク質の市場規模は、2025年から2030年にかけて4.93%のCAGRを記録し、2030年までに4億5,990万米ドルに達する見込みです。

脊椎固定術、外傷、小骨手術の発生率の増加と、より迅速な骨回復の需要が、BMP市場の成長を確約する主な要因です。

腰痛や脊椎椎間板脱臼は、最も一般的な職業病の一つです。このような障害の75％以上は、非侵襲的治療法では緩和が得られず、脊椎手術が必要となります。低侵襲手術、入院期間の短縮、早期回復は、患者の間でよく見られる要求です。BMPは、上記のような利点があるため、近年整形外科医の間で高い支持を得ています。

スポーツ関連の怪我、高齢人口の増加、骨移植に代わる骨誘導製品に関する認知度の向上も市場成長を促進する要因です。BMPは、ドナーの罹患率の欠如、大規模な外科処置、高い回復時間、痛みとしびれ、高コストなどの骨移植よりも優れた結果を報告しています。

骨形成タンパク質市場レポートハイライト：

  • rhBMP-2とrhBMP-7は、市販されている組み換えBMPです。rhBMP-2は、骨癒合術において骨と軟骨の形成を早める高い骨誘導性を持つことで広く知られています。
  • rhBMP-2セグメントは2024年に73.9%の最大市場シェアを占め、2025年から2030年にかけてより高いCAGRで成長すると予測されています。
  • rhBMP-7セグメントは、2025年から2030年にかけて緩やかなCAGRで成長すると予想されます。ヘルスケア専門家が骨修復のために自家移植に代わるものを探す傾向が強まる中、移植片の採取に伴う合併症なしに治癒を促進するrhBMP-7の能力は、臨床現場での採用を促進する可能性があります。
  • 脊椎固定術分野は、2024年に50.3％の最大市場シェアを占めました。この成長の背景には、効果的かつ効率的なソリューションの開発、従来の治療法よりもこれらのタンパク質が受け入れられつつあること、市場での地位を強化する研究イニシアティブが進行中であることなどがあります。
  • 北米は、2024年の骨形成タンパク質の世界市場で49.6%の最大市場シェアを占めています。整形外科手術の件数が多いこと、有利な償還政策が利用可能であることが、最大シェアの要因です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 骨形成タンパク質市場：タイプ別ビジネス分析

  • タイプセグメントダッシュボード
  • 世界の骨形成タンパク質市場タイプ変動分析
  • 世界の骨形成タンパク質市場規模と動向分析、タイプ別、2018～2030年
  • rHBMP-2遺伝子
  • rHBMP-7遺伝子

第5章 骨形成タンパク質市場：用途ビジネス分析

  • 用途セグメントダッシュボード
  • 世界の骨形成タンパク質市場の用途変動分析
  • 世界の骨形成タンパク質市場規模と動向分析、用途別、2018～2030年
  • 脊椎固定術
  • 外傷
  • 再建
  • 口腔顎顔面

第6章 骨形成タンパク質市場：タイプと用途別の地域推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測および動向分析、2018年から2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参入企業
  • 戦略マッピング
  • 企業市況分析、2024年
  • 参入企業の概要
    • Medtronic plc
    • Cellumed Co., Ltd.
    • Cell Guidance Systems LLC
    • Merck KGaA
    • Prospec-Tany Technogene Ltd.
    • Qkine Ltd.
    • Bio-Techne.
    • Thermo Fisher Scientific Inc.
    • Proteintech Group, Inc.
    • STEMCELL Technologies
    • Sartorius Stedim Biotech
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global Bone Morphogenetic Protein market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global Bone Morphogenetic Protein market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America Bone Morphogenetic Protein market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Bone Morphogenetic Protein market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 13 Mexico Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 15 Europe Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 18 UK Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 19 UK Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 20 Germany Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 22 France Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 23 France Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 24 Italy Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 25 Italy Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 26 Spain Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 27 Spain Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 28 Denmark Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 29 Denmark Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 30 Sweden Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 31 Sweden Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 32 Norway Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 33 Norway Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 37 Japan Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 38 Japan Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 39 China Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 40 China Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 41 India Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 42 India Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 43 Australia Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 44 Australia Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 45 Thailand Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 46 Thailand Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 47 South Korea Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 48 South Korea Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 49 Latin America Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 51 Latin America Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 52 Brazil Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 53 Brazil Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 54 Argentina Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 55 Argentina Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 59 South Africa Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 63 UAE Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 64 UAE Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 65 Kuwait Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 67 Participant's overview
  • Table 68 Financial performance

List of Figures

  • Fig. 1 Bone Morphogenetic Protein market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Bone Morphogenetic Protein market driver analysis
  • Fig. 12 Bone Morphogenetic Protein market restraint analysis
  • Fig. 13 Bone Morphogenetic Protein market: Porter's analysis
  • Fig. 14 Bone Morphogenetic Protein market: PESTEL analysis
  • Fig. 15 Bone Morphogenetic Protein market: Type outlook and key takeaways
  • Fig. 16 Bone Morphogenetic Protein market: Type market share analysis, 2023 - 2030
  • Fig. 17 rhBMP-2 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 rhBMP-7 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Bone Morphogenetic Protein market: Application outlook and key takeaways
  • Fig. 20 Bone Morphogenetic Protein market: Application market share analysis, 2023 - 2030
  • Fig. 21 Spinal Fusion market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Trauma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Recontructive market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Oral Maxillofacial market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 North America Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Bone Morphogenetic Protein market, 2018 - 2030 (USD Million)
  • Fig. 29 Mexico Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Europe Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 UK Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Germany Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 France Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Italy Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Spain Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Norway Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Asia-Pacific Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Japan Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 China Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 India Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Australia Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 MEA Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Key company categorization
  • Fig. 55 Company market positioning
  • Fig. 56 Market participant categorization
  • Fig. 57 Strategy framework
目次
Product Code: GVR-1-68038-226-6

Bone Morphogenetic Protein Market Growth & Trends:

The global bone morphogenetic protein market size is expected to reach USD 459.9 million by 2030, registering a CAGR of 4.93% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of spinal fusion, trauma, and small bone surgeries coupled with demand for faster bone recovery are the key drivers affirming growth of BMP market.

Low back pain and spinal disc dislocation are some of the most common occupational hazards. Over 75% of such disorders require spinal surgery after noninvasive treatment options are unable to provide any relief. Minimally invasive surgery, shorter hospital stays, and fast recovery are common demands observed among patients. BMP has gained high acceptance among orthopedic surgeons in recent years owing to its ability to cater above mentioned benefits

Sport-related injuries, growing geriatric population, and increasing awareness about osteoinduction products as an alternative to bone grafting are other drivers accentuating market growth. BMP has reported outstanding results over bone graft, such as lack of donor morbidity, extensive surgical procedure, higher recovery time, pain & numbness, and high cost.

Bone Morphogenetic Protein Market Report Highlights:

  • rhBMP-2 and rhBMP-7 are the commercially available recombinant BMPs. rhBMP-2 is widely known for its high osteoinductive property for faster formation of bone and cartilage in bone fusion procedures.
  • The rhBMP-2 segment held the largest market share of 73.9% in 2024 and is anticipated to grow at the higher CAGR from 2025 to 2030.
  • rhBMP-7 segment is expected to grow at a moderate CAGR from 2025 to 2030. As healthcare professionals increasingly look for alternatives to autografts for bone repair, rhBMP-7's ability to promote healing without the complications associated with harvesting grafts could drive its adoption in clinical practice.
  • The spinal fusion segment held the largest market share of 50.3% in 2024. The growth is attributed to the development of effective and efficient solutions, the increasing acceptance of these proteins over conventional treatments, and the ongoing research initiatives that strengthen their position in the market.
  • North America held the largest market share of 49.6% in the global bone morphogenetic protein market in 2024. High number of orthopedic surgical procedures, and availability of favorable reimbursement policies are drivers that can be attributed to for largest share.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for minimally invasive medical procedures
      • 3.2.1.2. Increasing incidence of sports-related injuries
      • 3.2.1.3. Increasing target population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complications associated with the use of Bone Morphogenic Proteins
      • 3.2.2.2. Availability of alternative treatments
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bone Morphogenetic Protein Market: Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global Bone Morphogenetic Protein Market Type Movement Analysis
  • 4.3. Global Bone Morphogenetic Protein Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. rhBMP-2
    • 4.4.1. Global rhBMP-2 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. rhBMP-7
    • 4.5.1. Global rhBMP-7 Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bone Morphogenetic Protein Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Bone Morphogenetic Protein Market Application Movement Analysis
  • 5.3. Global Bone Morphogenetic Protein Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Spinal Fusion
    • 5.4.1. Global Spinal Fusion Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Trauma
    • 5.5.1. Global TraumaMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Reconstruction
    • 5.6.1. Global Reconstruction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Oral Maxillofacial
    • 5.7.1. Global Oral Maxillofacial Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bone Morphogenetic Protein Market: Regional Estimates & Trend Analysis by Type and Application

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. North America Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Market and Competitive Scenario
      • 6.3.2.3. U.S. Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Market and Competitive Scenario
      • 6.3.3.3. Canada Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Market and Competitive Scenario
      • 6.3.4.3. Mexico Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Market and Competitive Scenario
      • 6.4.2.3. UK Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Market and Competitive Scenario
      • 6.4.3.3. Germany Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Market and Competitive Scenario
      • 6.4.4.3. France Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Market and Competitive Scenario
      • 6.4.5.3. Italy Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Market and Competitive Scenario
      • 6.4.6.3. Spain Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Market and Competitive Scenario
      • 6.4.7.3. Denmark Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Market and Competitive Scenario
      • 6.4.8.3. Sweden Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Market and Competitive Scenario
      • 6.4.9.3. Norway Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Market and Competitive Scenario
      • 6.5.2.3. Japan Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Market and Competitive Scenario
      • 6.5.3.3. China Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Market and Competitive Scenario
      • 6.5.4.3. India Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Market and Competitive Scenario
      • 6.5.5.3. Australia Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Market and Competitive Scenario
      • 6.5.6.3. Thailand Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Market and Competitive Scenario
      • 6.5.7.3. South Korea Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Market and Competitive Scenario
      • 6.6.2.3. Brazil Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Market and Competitive Scenario
      • 6.6.3.3. Argentina Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Market and Competitive Scenario
      • 6.7.2.3. South Africa Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Market and Competitive Scenario
      • 6.7.3.3. Saudi Arabia Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Market and Competitive Scenario
      • 6.7.4.3. UAE Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Market and Competitive Scenario
      • 6.7.5.3. Kuwait Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Participant's Overview
    • 7.4.1. Medtronic plc
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Cellumed Co., Ltd.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Cell Guidance Systems LLC
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Merck KGaA
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Prospec-Tany Technogene Ltd.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Qkine Ltd.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Bio-Techne.
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Thermo Fisher Scientific Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Proteintech Group, Inc.
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. STEMCELL Technologies
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Sartorius Stedim Biotech
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives